Episode summary
Capital One, Amex Shares Sink on Trump’s Credit-Card Threat | Bloomberg Intelligence
Bloomberg Intelligence
· · Hosts: Scarlet Fu, Alex Semenova, John Tucker · Guests: Nathan Dean, Poonam Goyal, Sam Fazeli, Geetha Ranganathan
Summary
The episode centered on market fallout from President Trump’s call for credit-card issuers to cap interest rates at 10% for a year. An analyst said the proposal cannot be implemented by presidential fiat, put the odds of it happening in 2026 at only 30%, and argued the more likely route is regulatory pressure through the Consumer Financial Protection Bureau. The analyst also said the biggest risk is to firms with heavy card exposure such as Capital One and American Express, because lower rates could force tighter underwriting, fewer card users, and weaker rewards economics.
The discussion then shifted to Lululemon, where a retail analyst said stronger fourth-quarter sales guidance is encouraging but not enough to prove a turnaround. The company’s problems were framed as execution and innovation issues rather than macro pressure, with the analyst expecting the next CEO and a more product-led strategy to matter more than the loyalty program.
Later segments covered Nvidia’s $1 billion, five-year partnership with Eli Lilly on AI drug development, which a pharmaceuticals analyst described as part of a broader industry-wide push to automate experiments and speed drug discovery. The episode closed on Paramount Skydance’s escalating fight for Warner Bros. Discovery, with a media analyst saying the company may need to raise its bid as it pressures shareholders and threatens a proxy fight.
Key takeaways
- The policy analyst said Trump cannot directly impose a 10% credit-card APR cap, and estimated only a 30% chance of it happening in 2026.
- The analyst said Capital One and American Express are more exposed than diversified banks because card revenue is a bigger share of their business.
- The retail analyst said Lululemon’s better-than-expected holiday sales still do not prove a turnaround because the core problem is weak execution and lack of innovation.
- The pharmaceuticals analyst said Nvidia’s $1 billion Eli Lilly investment is meant to automate lab work and speed drug discovery, not just make routine research easier.
- The media analyst said Paramount Skydance likely needs a higher bid, since only about 2% of Warner Bros. Discovery shares have been tendered so far.
Notable quotes
“there's no way that he can implement this”
“we only see a 30% chance of this happening in 2026”
“it does bring the member who enjoys the Lululemon experience to keep coming back”
“A billion dollars is probably a drop in the ocean for both of them”
“only about 2% of the shares have been t tendered which means that the shareholders are really waiting for a higher bid”
How the episode opens
Bloomberg Audio Studios, podcasts, radio, news. You're listening to the Bloomberg Intelligence Podcast. Catch us live weekdays at 10 a.m. Eastern on Apple CarPlay and Android Auto with the Bloomberg Business App.
Listen on demand wherever you get your podcasts or watch us live on YouTube. I look at the Bloomberg terminal and the top story all morning long has been about shares of Capital 1, AMX uh tumbling along with some other banks that issue credit cards following President Trump's uh announcement that he is calling on these companies to cap interest rates at 10% a year which uh could threaten their profits uh billions in profits for the industry. Let's bring in now Nathan Dean.
Nathan is our senior policy analyst at Bloomberg Intelligence. And Nathan, one thing that we need to make clear, uh, President Trump calling for this is not the same as him actually having the authority to do this. Is this something in which he has the authority to call for a cap on interest rates for credit card companies?
No, it's not. And that should be the first question that these investors look at is how would President Trump implement this? Because look, he said that in effective January 20th that there would be a one-year cap at 10%.
But really, there's no way that he can implement this. There has been legislation from senators uh Bernie Sanders, the independent, and obviously Josh Holly, the Republican, to actually put in a cap for five years, but that legislation really hasn't gone anywhere. Now, the industry averages around 21% going down to 10%.
Obviously, you're going to see a significant decline in what the interest would be to these banks, and obviously that we're starting to see it what the potential of that would be in the stock market.
From the episode’s captions: roughly the first two minutes, lightly cleaned. Keep watching on YouTube →
Topics
- credit card interest rate cap
- banking profits outlook
- retail earnings momentum
- ai drug research investment
- media merger battle
Companies and tickers mentioned
- COF
- AXP
- LULU
- NVDA
- LLY
- NFLX
- Capital One
- American Express
- Lululemon Athletica
- Nvidia
- Eli Lilly
- Paramount Skydance
- Warner Bros. Discovery
- Netflix
Watch the episode
Summary, takeaways and quote selection by Octagon. Quotes are short excerpts; the full conversation is in the episode.
More from Bloomberg Intelligence
-
Anthropic’s IPO Is Said to Be About Six Times Oversubscribed | Bloomberg Intelligence -
Instant Reaction: Nvidia CEO Jensen Huang Ousted by Nvidia Board | Bloomberg Intelligence -
Nvidia’s Huang Ousted by Board in Move That Roils AI Economy | Bloomberg Intelligence -
CoreWeave Shares Soar After AI Computing Firm Eases Debt Fears | Bloomberg Intelligence -
Anthropic Targets $1.4 Trillion Valuation in Blockbuster IPO | Bloomberg Intelligence -
Nvidia Probe Into CEO Affair Raises Thorny Questions for AI | Bloomberg Intelligence
Bloomberg Intelligence, this episode and its artwork belong to Bloomberg. Octagon is not affiliated with the show; this page is an independent summary.
